文献速递哮喘

呼气峰流速波动分析与哮喘治疗失败的相关性

Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

本研究对LOCCS试验中493名哮喘患者每日呼气峰流速(PEF)数据进行去趋势波动分析,评估PEF变异系数(CVpef)和标度指数α与治疗失败的关系。结果显示治疗失败者CVpef更高,治疗期F和F+S组α更高,但α变化模式个体差异大。提示PEF波动自相似性增加与治疗失败相关。

要点

  • PEF变异系数(CVpef)升高与哮喘治疗失败相关。
  • 治疗期标度指数α在F和F+S组治疗失败者中更高。
  • α变化模式个体差异大,需个体化解读。

核心结论

  • 肺功能波动性增加(CVpef升高)且时间自相似性(α)增加与哮喘治疗失败相关。
  • 治疗失败前α的变化模式存在个体差异。

研究设计与样本

  • 对LOCCS试验中493名参与者每日一次PEF数据进行去趋势波动分析。
  • 评估CVpef和标度指数α与治疗失败的关系。

主要发现

  • 在F和F+S组治疗失败者中,CVpef在导入期和干预期均更高。
  • 治疗期F和F+S组治疗失败者α更高。
  • 所有三组治疗失败前α变化模式不一。

临床怎么用

  • 可考虑将PEF波动分析用于哮喘治疗失败的预测评估。
  • 需注意α变化模式个体差异,不宜统一解读。

局限性

  • 研究基于LOCCS试验数据,结论外推需谨慎。
  • α变化模式个体差异大,预测价值受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Temporal fluctuations have been demonstrated in lung function and asthma control, but the effect of controller therapy on these fluctuations is unknown. OBJECTIVES: To determine if fluctuations in peak expiratory flow (PEF) are predictive of subsequent treatment failure and may be modified by controller therapy. METHODS: We applied detrended fluctuation analysis to once-daily PEF data from 493 participants in the LOCCS (Leukotriene Modifier Corticosteroid or Corticosteroid-Salmeterol) trial of the American Lung Association Airways Clinical Research Centers. We evaluated the coefficient of variation of PEF (CVpef) and the scaling exponent α, reflecting self-similarity of PEF, in relation to treatment failure from the run-in period of open-label inhaled fluticasone, and the treatment periods for subjects randomized to (1) continued twice daily fluticasone (F), (2) once daily fluticasone plus salmeterol (F + S), or (3) once daily oral montelukast (M). MEASUREMENTS AND MAIN RESULTS: The CVpef was higher in those with treatment failure in the F and F + S groups in the run-in phase, and all three groups in the treatment phase. α was similar between those with and without treatment failure in all three groups during the run-in phase but was higher among those with treatment failure in the F and F + S groups during the treatment phase. Participants in all three groups showed variable patterns of change in α leading up to treatment failure. CONCLUSIONS: We conclude that increased temporal self-similarity (α) of more variable lung function (CVpef) is associated with treatment failure, but the pattern of change in self-similarity leading up to treatment failure is variable across individuals.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Kaminsky DA, Wang LL, Bates JH, et al. Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma. Am J Respir Crit Care Med. 2017. PMID: 27814453. doi:10.1164/rccm.201601-0076OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。